Given the sharp spreading of COVID-19 pandemic all around the world, our attention was brought to consider that that many cationic drugs (i.e. those characterized by the presence, at physiological pH value, of one or more cationic groups, both primary, secondary, tertiary and guanidinic aminic groups) could have any effect in impairing SARS-CoV2 entry in the host cell. This could open to new therapeutic chances against COVID-19.
Cationic drugs and COVID-19 / O.V. Brenna, S.S. Torretta, L. Pignataro, F. Di Berardino. - In: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. - ISSN 2058-7384. - 34(2020), pp. 1-3.
Cationic drugs and COVID-19
O.V. BrennaPrimo
;S.S. Torretta
Secondo
;L. PignataroPenultimo
;F. Di BerardinoUltimo
2020
Abstract
Given the sharp spreading of COVID-19 pandemic all around the world, our attention was brought to consider that that many cationic drugs (i.e. those characterized by the presence, at physiological pH value, of one or more cationic groups, both primary, secondary, tertiary and guanidinic aminic groups) could have any effect in impairing SARS-CoV2 entry in the host cell. This could open to new therapeutic chances against COVID-19.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2058738420966078(1).pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
111.04 kB
Formato
Adobe PDF
|
111.04 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
